Ftse Mib
33.414,56
0,46%
DAX
19.626,45
1,05%
S&P 500
6.032,38
0,56%
NASDAQ
19.218,17
0,83%
Bitcoin
96.401,77
-1,11%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Durect Corp (DRRX) Durect Corp (DRRX) Notizie

DRRX

Durect (DRRX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:DRRX
DataOraFonteTitoloSimboloCompagnia
29/11/202420:30Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:DRRXDurect Corp
25/11/202415:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DRRXDurect Corp
25/11/202412:00PR Newswire (US)DURECT Corporation Announces Sale of ALZET® Product Line to Lafayette Instrument Co. for $17.5 MillionNASDAQ:DRRXDurect Corp
14/11/202422:15Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:DRRXDurect Corp
14/11/202422:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DRRXDurect Corp
17/10/202414:30PR Newswire (US)DURECT Corporation to Present Data on Larsucosterol at The Liver Meeting 2024NASDAQ:DRRXDurect Corp
16/10/202422:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DRRXDurect Corp
25/09/202414:00PR Newswire (US)DURECT Corporation Announces Phase 3 Registrational Trial Design for Larsucosterol in Alcohol-associated HepatitisNASDAQ:DRRXDurect Corp
04/09/202422:30PR Newswire (US)DURECT Corporation to Present at the H.C. Wainwright Global Investment ConferenceNASDAQ:DRRXDurect Corp
26/08/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:DRRXDurect Corp
14/08/202423:01Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:DRRXDurect Corp
12/08/202422:15Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:DRRXDurect Corp
12/08/202422:10Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:DRRXDurect Corp
12/08/202422:05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:DRRXDurect Corp
02/08/202422:30Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:DRRXDurect Corp
21/05/202414:00PR Newswire (US)DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated HepatitisNASDAQ:DRRXDurect Corp
13/05/202422:05PR Newswire (US)DURECT Corporation Reports First Quarter 2024 Financial Results and Business UpdateNASDAQ:DRRXDurect Corp
07/05/202422:30PR Newswire (US)DURECT Corporation to Announce First Quarter 2024 Financial Results and Provide a Business UpdateNASDAQ:DRRXDurect Corp
30/04/202413:00PR Newswire (US)DURECT Corporation Announces Late-Breaking Oral Presentation at the EASL Congress 2024 to Discuss AHFIRM Phase 2b Data in Alcohol-Associated HepatitisNASDAQ:DRRXDurect Corp
27/03/202421:01PR Newswire (US)DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:DRRXDurect Corp
20/03/202421:30PR Newswire (US)DURECT Corporation to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide a Business UpdateNASDAQ:DRRXDurect Corp
04/03/202413:00PR Newswire (US)DURECT and Charles River Laboratories Enter into Co-Marketing and Collaboration Agreement for ALZET® Product Line in U.S. and CanadaNASDAQ:DRRXDurect Corp
14/02/202422:16Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:DRRXDurect Corp
08/02/202400:48PR Newswire (US)DURECT Corporation to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:DRRXDurect Corp
13/11/202322:05PR Newswire (US)DURECT Corporation Reports Third Quarter 2023 Financial Results and Business UpdateNASDAQ:DRRXDurect Corp
09/11/202322:30PR Newswire (US)DURECT Corporation to Announce Third Quarter 2023 Financial Results and Provide a Business UpdateNASDAQ:DRRXDurect Corp
07/11/202322:01PR Newswire (US)DURECT Corporation Announces Topline Results from Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated Hepatitis with Promising Effect on MortalityNASDAQ:DRRXDurect Corp
07/09/202313:00PR Newswire (US)DURECT Corporation Announces Last Patient Last Visit in Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated HepatitisNASDAQ:DRRXDurect Corp
31/08/202322:30PR Newswire (US)DURECT Corporation Announces Presentations in Upcoming Investor ConferencesNASDAQ:DRRXDurect Corp
09/08/202322:05PR Newswire (US)DURECT Corporation Reports Second Quarter 2023 Financial Results and Business UpdateNASDAQ:DRRXDurect Corp
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:DRRX

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
BAMI
Banco BPM
BIT
STLAM
Stellantis NV
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ENI
Eni
BIT
ENEL
Enel
BIT
STMMI
ST Microelectronics
BIT
TIT
Telecom Italia
BIT
MONC
Moncler
BIT
TEN
Tenaris
BIT
RACE
Ferrari NV
BIT
MB
Mediobanca Banca di Cred...
BIT
G
Generali
BIT
BPE
Bper Banca
BIT
SPM
Saipem
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network